Malta - engelsk - Medicines Authority

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - valsartan - film-coated tablet - valsartan 80 mg - agents acting on the renin-angiotensin system

Armenia - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

siegfried barbera s.l. - valsartan - tablets film-coated - 80mg

Armenia - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis farma s.p.a - valsartan - tablets film-coated - 80mg

USA - engelsk - NLM (National Library of Medicine)

rebel distributors corp - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - valsartan 80 mg - diovan® (valsartan) is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. diovan is indicated for the treatment of heart failure (nyha class ii-iv). in a controlled clinical trial, diovan significantly reduced hospitalizations for heart failure. there is no evidence that diovan provides added benefits when it is used with an adequate dose of an ace inhibitor. [ see  clinical studies (14.2)]   in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction, diovan is indicated to reduce cardiovascular mortality. [ see  clinical studies (14.3 ) ] none teratogenic effects: pregnancy category d diovan, like other drugs that act on the renin angiotensin system, can cause fetal and neonatal morbidity and death when used during the second or third trimester of pregnancy. diovan can cause fetal harm when administered to a pregnant woman. if this drug is used during pregnancy, or if the p

Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

generics pharma hellas ltd (0000003679) 63, ag. dimitriou str., alimos, athens, 17456 - valsartan - film coated tablets - 80mg - valsartan (8000001531) 80mg

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - hydrochlorothiazide 12.5mg;  ; valsartan 80mg;  ;  ;   - film coated tablet - 12.5mg/80mg - active: hydrochlorothiazide 12.5mg   valsartan 80mg       excipient: colloidal silicon dioxide crospovidone hypromellose iron oxide red iron oxide yellow macrogol 8000 magnesium stearate powdered cellulose purified talc titanium dioxide - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. these fixed dose combinations should be used as second line.

Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589) - valsartan - 膜衣錠 - valsartan (2408005100) mg - valsartan - 治療成人和6-18 歲的兒童或青少年高血壓、心衰竭(nyha 二到四級)、心肌梗塞後左心室功能異常。

Malta - engelsk - Medicines Authority

krka dd novo mesto Šmarješka cesta 6, 8501 novo mesto, slovenia - valsartan - film-coated tablet - valsartan 80 mg - agents acting on the renin-angiotensin system

Malta - engelsk - Medicines Authority

macleods pharma españa, s.l.u. avenida diagonal, 468, 6°, puerta a, 08006, barcelona, spain - valsartan - film-coated tablet - valsartan 80 mg - agents acting on the renin-angiotensin system

Bulgaria - bulgarsk - Изпълнителна агенция по лекарствата

80 mg film - coated tablets